Importer of Controlled Substances Application: National Center for Natural Products Research

Issuing agencies

Abstract

National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 200 (Monday, October 19, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 200 (Monday, October 19, 2026)]
[Notices]
[Pages 66154-66155]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-21358]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1782]


Importer of Controlled Substances Application: National Center 
for Natural Products Research

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: National Center for Natural Products Research has applied to 
be registered as an importer of basic class(es) of controlled 
substance(s). Refer to Supplementary Information listed below for 
further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants, therefore, may submit electronic comments on, or 
objections to the issuance of the proposed registration on or before 
November 18, 2026. Such persons may also file a written request for a 
hearing on the application on or before November 18, 2026.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal

[[Page 66155]]

Register Representative/DPW, 8701 Morrissette Drive, Springfield, 
Virginia 22152. All requests for a hearing should also be sent to: Drug 
Enforcement Administration, Attn: Administrator, 8701 Morrissette 
Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on September 7, 2026, National Center for Natural 
Products Research, 806 Hathorn Road, 135 Coy Waller Lab, University, 
Mississippi 38677, applied to be registered as an importer of the 
following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
          Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Marihuana...............................            7360               I
Tetrahydrocannabinols...................            7370               I
------------------------------------------------------------------------

    The company plans to acquire new genetic materials with different 
cannabinoid profiles for research and manufacturing purposes. No other 
activities for these drug codes are authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Justin Wood,
Deputy Assistant Administrator.
[FR Doc. 2026-21358 Filed 10-16-26; 8:45 am]
BILLING CODE 4410-09-P


</pre></body>
</html>